drugset / Trial / NCT00924742
A Single-Dose Pharmacokinetics Study of Tapimycin Injection
Non-randomizedSingle-groupOpen-label
Summary
The purpose of this study is to examine the pharmacokinetic properties of Tapimycin injection (piperacillin 4 g + tazobactam 0.5 g powder for injection) in healthy volunteers under fasting conditions.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-04
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Piperacillin | Small molecule | 4 g | Intravenous |
| Subject | Tazobactam | Small molecule | 0.5 g | Intravenous |
Indications
No indication recorded.